DeepSeq.AI

DeepSeq.AI

Private
Sacramento, CaliforniaHealthcare & Life Scienceshttps://www.deepseq.ai

Last Round

Grant

May 21, 2025

Total Funding Raised

$624,797

Momentum Score

75 /100

Company Overview

DeepSeq.AI is a biotechnology company that specializes in AI-driven drug discovery. The company's platform integrates high-throughput wet lab assays with explainable generative AI to design and optimize biologics. This technology generates large-scale protein function data and models protein "grammar" to develop therapeutics tailored for specific functions like conditional binding, manufacturability, and efficacy. The company has received investments from biotech accelerators such as Merck DSS and UC Berkeley SkyDeck, and has been awarded an NSF SBIR grant. DeepSeq.AI collaborates with pharmaceutical companies to accelerate the development of novel drug candidates.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Application

Keywords

protein engineeringAI drug discoverygenerative AI platformAI protein designgenerative biologybiologics discoveryin silico designhigh-throughput screeningsequence optimizationprotein therapeuticswet-lab screeningexplainable AIprotein library designpandemic preparednessSmall Business Innovation ResearchSBIR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DeepSeq.AI Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

DeepSeq.AI Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantMay 21, 2025
GrantJul 15, 2024
Pre SeedNov 1, 2023

Key People

Founding team and executive leadership

Andrew Chang

Co-Founder CEO

Founding Team

DeepSeq.AI Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 5, 2026

    CEO Andrew Chang to present at SynBioBeta conference on May 5, 2026.

DeepSeq.AI Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DeepSeq.AI Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DeepSeq.AI's valuation, stock price, and market status.

Firmographic Details

HeadquartersSacramento, California
Employee Range6
Year Founded2019
Last FundingMay 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.